• The Korean Journal of Nuclear Medicine Technology
• /
• v.12 no.1
• /
• pp.3-12
• /
• 2008

Purpose: Contaminated clothes and bedclothes of patients by mouth or with excrement are produced after Radioisotope $^{131}I$ treatment. In this paper, patient's clothes and bedclothes contaminated by radioactivity measured and radioactive waste wish to calculate optimum storage period. Material and Methods: The whole area of patients' clothes and bedclothes measured 70 patients, 12 males and 58 females, who had radioisotope $^{131}I$ therapy between August 2005 and February 2006. Assuming contamination is evenly distributed, the radioscope used to measure up to social toleration level at 7 day intervals. Results: Each optimum storage period of control group of 60 case and non control group of 10 case were average $44{\pm}16$ days and $32{\pm}13$ days. Decontamination effect of surface contamination for radioactive waste was average $83.66{\pm}15.15%$. Conclusion: It is important that classify radioactive waste according to difference of surface contamination. Result of this research, handling radioactive waste in optimum storage period may be useful.

• The Korean Journal of Nuclear Medicine
• /
• v.24 no.1
• /
• pp.80-86
• /
• 1990

Fifty seven patients with differentiated thyroid carcinoma were performed radioactive iodine-131 whole body scans after administration of diagnostic dose $(2\sim10\;mCi)$ and therapeutic dose $(30\sim150\;mCi)$ within three months. We evaluated the state of radioactive iodine-131 uptakes in whole body scan to detect correct metastasis of thyroid carcinoma. The results are as follows: 1) In 20 of the 57 patients (35%), the therapeutic scan showed the additional uptakes that were not seen in the diagnostic scan. 2) In 9 (64.2%) of the 14 patients who had been received the thyroid ablation theraphy with I-131 previously, new additional lesions were found in the therapeutic scan but only 11 (25%) of the 32 patients who had not been received the thyroid ablation theraphy disclosed new uptake lesions (p < 0.01). 3) The additional uptake lesions of therapeutic scan were significantly more common in the bony metastatic foci (55.7%) than other areas (p < 0.01). In 11 (55%) of 20 patients, additional uptake regions were anterior neck areas (thyroid bed or regional lymph node). We conclude that diagnostic scan with $2\sim5$ mCi I-131 is inadequate in evaluating residual iodine avid tissues of patients with thyroid carcinoma. Also post-theraphy I-131 whole body scan would be important to evaluate the correct staging and prognosis of thyroid carcinoma, and to follow-up patients.

• Proceedings of the Korean Magnestics Society Conference
• /
• 2008.12a
• /
• pp.245.2-245.2
• /
• 2008

• Journal of Radiation Protection and Research
• /
• v.39 no.1
• /
• pp.61-64
• /
• 2014

Radioactive materials are in use and have many applications from the generation of electricity to the purposes of research, industry and medicine such as diagnosis and therapy. In the course of their use some of radioactive substances may be discharged into the environment from facilities using the unsealed radioactive materials, which are main artificial sources occurring the public exposure. Discharges are in the form of gases, particles or liquids. This paper provides procedures to estimate the level of the public exposure based on the conservative assumptions and simple calculations in the facility using unsealed liquid sources. They consist of two processes; (1) to calculate maximum concentration of gaseous effluents discharged through the exhaust pipe and average concentration of liquid effluents discharged through the drain of the storage tank, (2) to compare each of them to numerical guidances for the discharges of radioactive gaseous and liquid effluents mentioned in the related notification. For this purpose followings are assumed properly; daily usage, form and dispersion rate of radionuclides, daily amount of radioactive liquid waste and exhaust and drainage equipment. The procedures are readily applicable to evaluate environmental effects by planned effluent discharges from facilities using the unsealed radioactive materials. In addition they may be utilized to obtain practical requirements for radiation safety control necessary for the reductions of the public exposure.

• The Journal of Internal Korean Medicine
• /
• v.39 no.1
• /
• pp.9-21
• /
• 2018

Objective: Graves' disease, the most common cause of primary hyperthyroidism, is a thyroid specific autoimmune disorder. When resistance to medication is shown in spite of long term therapy with anti-thyroid drugs, radioactive iodine therapy would be chosen in Western medicine. However, this therapy has often been reported to cause patients have hypothyroidism, thus requiring them to take levothyroxine for the rest of their lives. In this study, we evaluate the clinical efficacy and safety of Ahnjeonbaekho-tang (AJBHT) on patients with Graves' disease. Methods: We prescribed AJBHT for 3 months to two groups: patients who had been taking antithyroid drugs were administered AJBHT after discontinuing the antithyroid drugs ($Com-Tx{\rightarrow}Single-Tx$), and patients who had not been taking antithyroid drugs were started with AJBHT (Single-Tx) immediately. We evaluated the thyroidal function test (TFT) and visual analogue scale (VAS) for clinical symptoms for 3 months. Results: Serum T3 and fT4 were significantly decreased in both groups and remission rate of thyroidal hormones were significantly improved in the Single-Tx group. The clinical symptoms of palpitation, fatigue, and heat intolerance were significantly improved in both groups. In the safety analysis, all patients were in normal range of liver, renal function blood test and common blood count. Conclusion: From these results, we suggested that AJBHT was effective on TFT and clinical symptoms of Graves' disease. The study supports that AJBHT may be a useful agent for patients with Graves' disease who are resistant to antithyroid medication or radioactive iodine therapy, and for patients at first diagnosis.

• Journal of the Korea Safety Management & Science
• /
• v.17 no.4
• /
• pp.241-246
• /
• 2015

Generally a patient who was injected radiopharmaceuticals for nuclear medicine examination is not an object of isolation. Therefore, when the patient uses toilet, we expect surface contamination of a toilet by radioisotope. The measured value is $25.69Bq/cm^2$(a restroom near admission and administration), $19.39Bq/cm^2$(a toilet near department of radiology). The study shows that 9 of 24 locations in controlled area exceed over surface contamination limit. From now on, we should find source of contamination through measurement radioactive nuclide to apply radiation safety management.

• The Korean Journal of Nuclear Medicine
• /
• v.2 no.1
• /
• pp.49-52
• /
• 1968

The influence of estradiol on the radioactive calcium metabolism in blood, bone and young of lactating rats has been studied. Estrogen, in an amount estimated to equal that secreted in late pregnancy, was injected daily into lactating rats for 4 days along with $^{45}Ca$. On the 5th day, radioactivity of blood serum, bone, and young was compared to a similar group of lactating rats not treated with estrogen. Average gain in weight of the litters of the 2 groups was similar. However, radioactivity in serum and bones of treated with estradiol was significantly higher than in the controls. The radioactivity in litters of the 2 groups was similar. Estrogen plays a role in the retention of calcium in the animal body.

• Asian Pacific Journal of Cancer Prevention
• /
• v.14 no.11
• /
• pp.6209-6213
• /
• 2013

Well differentiated thyroid cancers (WDTC), including papillary (80%) and follicular (10%) types, are the most common endocrine cancers globally. Over the last few decades most the diagnosed cases have fallen into low risk categories. Radioactive iodine-131 (RAI) has an established role in reducing recurrence and improving the survival in high risk patients. In patients with primary tumor size <1 cm, RAI is not recommended by many thyroid societies. However, low risk WDTC has been an arena of major controversies, most importantly the role and dose of adjuvant RAI for remnant ablation to minimize chances of recurrence and improving survival. This review is an attempt to update readers about the previous and existing practice based on results of non-randomized trials and evolving trends fueled by recently published randomized studies.

• 대한핵의학회:학술대회논문집
• /
• 1967.11a
• /
• pp.101.4-102
• /
• 1967

• 대한핵의학회:학술대회논문집
• /
• 1967.11a
• /
• pp.99.1-99.1
• /
• 1967